Laboratorios Farmaceuticos Rovi SA
Laboratorios Farmaceuticos Rovi S.../ ES0157261019 /
ROVI/E
|
11/6/2024 9:50:50 AM
|
Chg.
-
|
Volume |
Bid9/26/2024 |
Ask10/24/2024 |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
77.47EUR
|
-
|
183
Turnover: 14,158.33 |
-Bid Size: - |
-Ask Size: - |
3.53 bill.EUR |
1.98% |
20.44 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
3.20 EUR |
-14.21% |
| EPS Diluted: |
- EUR |
-14.21% |
| Revenues per Share: |
15.36 EUR |
1.44% |
| Book Value per Share: |
9.99 EUR |
3.73% |
| Cash Flow per Share: |
2.10 EUR |
-52.34% |
| Dividend per Share: |
1.29 EUR |
35.39% |
| Total |
in th. |
|
| Revenues: |
829,509.00 EUR |
1.44% |
| Net Income: |
170,335.00 EUR |
-14.69% |
| Operating Cash Flow: |
113,247.00 EUR |
- |
| Cash and Cash Equivalents: |
25,322.00 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
20.44 |
18.81 |
| P/S Ratio: |
4.26 |
3.92 |
| P/BV ratio: |
6.55 |
6.03 |
| P/CF Ratio: |
31.19 |
28.71 |
| PEG: |
-1.44 |
-1.32 |
| Earnings Yield: |
4.89% |
5.32% |
| Dividend Yield: |
1.98% |
2.15% |
| Market Capitalization |
|
| Market Capitalization: |
3.53 bill. EUR |
3.25 bill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
1.67 mill. EUR |
1.54 mill. EUR |
| Shares Outstanding: |
54.02 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
26.55% |
| Net Profit Margin: |
20.53% |
| Return on Equity: |
31.58% |
| Return on Assets: |
21.30% |
Financial Strength
| Liquidity I / Cash Ratio: |
12.67% |
| Liquidity II / Quick Ratio: |
84.38% |
| Liquidity III / Current Ratio: |
254.87% |
| Debt / Equity Ratio: |
48.30% |
| Dynam. Debt / Equity Ratio: |
230.03% |
Efficiency
| Employees: |
2,111 |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
392,946.00 EUR |
| Net Income / Employee: |
80,689.25 EUR |
| Total Assets / Employee: |
378,912.36 EUR |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
